Quick Answer
Hepion Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $0.88 (loss) per share for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed an increase of +99.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2016 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2025), Hepion Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 39.7%.
- Historical annual values: Fiscal year 2025: $0.88 (loss) per share | Fiscal year 2024: $107.35 (loss) per share | Fiscal year 2023: $616.07 (loss) per share | Fiscal year 2022: $11.90 (loss) per share | Fiscal year 2021: $0.47 (loss) per share | Fiscal year 2020: $2.10 (loss) per share | Fiscal year 2018: $1.39 (loss) per share | Fiscal year 2017: $2.41 (loss) per share | Fiscal year 2016: $0.63 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: